StockData
Harrow, Inc. logo

Harrow, Inc. (HROW) stock

HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$32.16+2.64 (+8.94%)

Close on Nov 18, 2026Market cap $1.21BP/E –Yield –

Harrow net income

Net income is the profit left for shareholders after every expense, interest and tax.

Harrow's net income for the twelve months ending Jun 30, 2026 was -$37.23M. For fiscal 2025 it was -$5.14M. The highest annual figure on record is $14.63M in fiscal 2018.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.14M–
FY2024Dec 31, 2024-$17.48M–
FY2023Dec 31, 2023-$24.41M–
FY2022Dec 31, 2022-$14.09M–
FY2021Dec 31, 2021-$18.01M–
FY2020Dec 31, 2020-$3.36M-2098.2%
FY2019Dec 31, 2019$168.00K-98.9%
FY2018Dec 31, 2018$14.63M–
FY2017Dec 31, 2017-$11.99M–
FY2016Dec 31, 2016-$19.09M–
FY2015Dec 31, 2015-$15.90M–
FY2014Dec 31, 2014-$10.12M–
FY2013Dec 31, 2013-$7.64M–
FY2012Dec 31, 2012-$5.38M–
FY2011Dec 31, 2011-$953.94K–
FY2010Dec 31, 2010-$2.53M–
FY2009Dec 31, 2009-$4.55M–
FY2008Dec 31, 2008-$3.30M–
FY2007Dec 31, 2007-$4.28M–
FY2006Dec 31, 2006-$584.23K–
FY2005Dec 31, 2005-$539.62K–
FY2004Dec 31, 2004-$508.23K–
FY2003Dec 31, 2003-$207.20K–
FY2002Dec 31, 2002-$228.22K–
FY2001Dec 31, 2001-$208.42K–
FY2000Dec 31, 2000-$213.09K–
FY1999Dec 31, 1999-$204.00K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$17.27M-445.7%
Q1 FY2026Mar 31, 2026-$27.60M–
Q4 FY2025Dec 31, 2025$6.63M-2.2%
Q3 FY2025Sep 30, 2025$1.02M–
Q2 FY2025Jun 30, 2025$5.00M–
Q1 FY2025Mar 31, 2025-$17.78M–
Q4 FY2024Dec 31, 2024$6.78M–
Q3 FY2024Sep 30, 2024-$4.22M–
Q2 FY2024Jun 30, 2024-$6.47M–
Q1 FY2024Mar 31, 2024-$13.57M–
Q4 FY2023Dec 31, 2023-$9.15M-967.1%
Q3 FY2023Sep 30, 2023-$4.39M–
Q2 FY2023Jun 30, 2023-$4.23M–
Q1 FY2023Mar 31, 2023-$6.64M–
Q4 FY2022Dec 31, 2022$1.06M–
Q3 FY2022Sep 30, 2022-$6.46M–
Q2 FY2022Jun 30, 2022-$6.24M–
Q1 FY2022Mar 31, 2022-$2.44M-1223.5%
Q4 FY2021Dec 31, 2021-$7.42M-745.6%
Q3 FY2021Sep 30, 2021-$8.33M-196.4%
Q2 FY2021Jun 30, 2021-$2.48M–
Q1 FY2021Mar 31, 2021$217.00K–
Q4 FY2020Dec 31, 2020$1.15M-56.8%
Q3 FY2020Sep 30, 2020$8.64M–
Q2 FY2020Jun 30, 2020-$237.00K–
Q1 FY2020Mar 31, 2020-$12.91M-213.6%
Q4 FY2019Dec 31, 2019$2.66M-85.3%
Q3 FY2019Sep 30, 2019-$11.47M–
Q2 FY2019Jun 30, 2019-$2.38M-194.3%
Q1 FY2019Mar 31, 2019$11.36M–
Q4 FY2018Dec 31, 2018$18.13M–
Q3 FY2018Sep 30, 2018-$2.51M–
Q2 FY2018Jun 30, 2018$2.52M+69.9%
Q1 FY2018Mar 31, 2018-$3.51M–
Q4 FY2017Dec 31, 2017-$2.77M–
Q3 FY2017Sep 30, 2017-$5.69M–
Q2 FY2017Jun 30, 2017$1.48M–
Q1 FY2017Mar 31, 2017-$5.01M–
Q4 FY2016Dec 31, 2016-$6.10M–
Q3 FY2016Sep 30, 2016-$3.85M–

More Harrow figures

See a number that looks wrong?